Overview

Green Tea Extract in Treating Patients With Actinic Keratosis

Status:
Terminated
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Green tea extract contains ingredients that may inhibit the growth of actinic keratosis. PURPOSE: Randomized phase II trial to determine the effectiveness of green tea extract in treating patients who have actinic keratosis.
Phase:
Phase 2
Details
Lead Sponsor:
Frank Meyskens
University of California, Irvine
Collaborator:
National Cancer Institute (NCI)